According to a report released on June 29, 2011 by the Institute of Medicine (IOM) in the United States, over 116 million adults are burdened by chronic pain. This number is higher than cardiovascular disease, cancer and diabetes combined.
According to the 2010 Media Planner of Pain Medicine News, over 100,000 pain practitioners prescribed $23.5 billion in pain medication in 2009 alone.
According to a health special published by TIME Magazine in its March 7, 2011 issue, chronic pain is now being recognized as a disease rather than as a consequence of a disease. This has vast implications.
There has been no way to measure the severity and seriousness of pain. An article in the July 5 2011 issue of The Wall Street Journal highlights this fact very well. However, help is at hand. Chronic pain affects the Autonomic Nervous System (ANS) and DyAnsys has been able to show that ANS monitoring of patients with chronic pain allows one to measure a baseline and monitor the improvement in the pain condition.
The solution offered by DyAnsys through the technology of the ANSiscope® and auricular neurostimulation allows the pain practitioner to treat the patient with a non-narcotic method and allows the medical professional to objectively monitor the progress of the patient as the treatment unfolds.
